Reconstitution of Human Rrna Gene Transcription in Mouse Cells by A

Total Page:16

File Type:pdf, Size:1020Kb

Reconstitution of Human Rrna Gene Transcription in Mouse Cells by A ß 2014. Published by The Company of Biologists Ltd | Journal of Cell Science (2014) 127, 3309–3319 doi:10.1242/jcs.146787 RESEARCH ARTICLE Reconstitution of human rRNA gene transcription in mouse cells by a complete SL1 complex Kensaku Murano1, Mitsuru Okuwaki1, Fumitaka Momose2, Michiko Kumakura1, Shuhei Ueshima1, Robert F. Newbold3 and Kyosuke Nagata1,* ABSTRACT TIF-IA are functionally interchangeable between humans and mice, whereas the SL1/TIF-IB complex must be derived from the An important characteristic of the transcription of a ribosomal RNA same species to support rDNA transcription (Bell et al., 1990; gene (rDNA) mediated by DNA-dependent RNA polymerase (Pol) I Heix and Grummt, 1995; Learned et al., 1985; Mishima et al., is its stringent species specificity. SL1/TIF-IB is a key complex for 1982; Rudloff et al., 1994; Schnapp et al., 1993). The human SL1 species specificity, but its functional complex has not been complex contains the TATA-binding protein (TBP) and three reconstituted. Here, we established a novel and highly sensitive TBP-associated factors known as TAFIA (also known as TAFI48 monitoring system for Pol I transcription to reconstitute the SL1 and TAF1A), TAFIB (also known as TAFI63 and TAF1B) and activity in which a transcript harboring a reporter gene synthesized TAFIC (also known as TAFI110C and TAF1C) (Comai et al., by Pol I is amplified and converted into translatable mRNA by 1992). Among these SL1 components, TBP is interchangeable the influenza virus RNA-dependent RNA polymerase. Using this between humans and mice, indicating that TAFIs are responsible monitoring system, we reconstituted Pol I transcription from the for the promoter selectivity of SL1/TIF-IB (Rudloff et al., 1994). human rDNA promoter in mouse cells by expressing four human UV cross-linking experiments have demonstrated that TAFIA and TATA-binding protein (TBP)-associated factors (TAFIs) in the SL1 TAFIB bind to both the homologous and heterologous promoters, complex. The reconstituted SL1 also re-activated human rDNA suggesting that a binding of SL1/TIF-IB to the heterologous transcription in mouse A9 cells carrying an inactive human promoter precludes a formation of productive initiation chromosome 21 that contains the rDNA cluster. Chimeric SL1 complexes (Rudloff et al., 1994). There are contradictory complexes containing human and mouse TAFIs could be formed, reports about reconstituting SL1/TIF-IB activity in vitro. It has but these complexes were inactive for human rDNA transcription. been reported that the three recombinant human TAFIs and the TBP are necessary and sufficient to reconstitute a We conclude that four human TAFIs are necessary and sufficient to overcome the barrier of species specificity for human rDNA transcriptionally active human SL1 complex (Zomerdijk et al., transcription in mouse cells. 1994). In contrast, three mouse recombinant TAFIs and the TBP complex did not reconstitute the TIF-IB activity in an in vitro KEY WORDS: Ribosomal RNA gene, Transcription, Species transcription system (Heix et al., 1997). Later, a further TAFI, specificity, RNA polymerase I, SL1, TIF-IB TAFID (also known as TAFI41 and TAF1D), was identified from the TBP-antibody affinity-purified SL1 fraction (Gorski et al., INTRODUCTION 2007). TAFID co-migrates with TBP on SDS-PAGE, so it One of the most important rDNA transcription issues to be remained unidentified for more than 10 years following the initial addressed is the molecular mechanism of its stringent species identification of the SL1 complex (Comai et al., 1992). TAFIDis specificity (Heix and Grummt, 1995). Three decades ago, involved in rDNA transcription in vivo (Gorski et al., 2007). Grummt et al. demonstrated that in vitro transcription of human Thus, we hypothesize that TAFID is a final component in and mouse rDNAs requires completely homologous extracts reconstituting the human SL1 activity in mouse cells and (Grummt, 1981; Grummt et al., 1982), i.e. human rDNA is not overcoming the rDNA transcription species barrier. transcribed in mouse cell extracts and vice versa. This distinct To examine this hypothesis, we established a novel and highly promoter recognition specificity of Pol I is mediated by a multi- sensitive monitoring system for Pol I transcription. The products subunit factor called SL1 in humans and TIF-IB in mice. SL1/ synthesized by Pol I are not translated to proteins. We tried to TIF-IB recruits Pol I on the rDNA promoter through RRN3/TIF- overcome this problem using the influenza virus RNA-dependent IA and stabilizes the binding of the upstream binding factor RNA polymerases (RdR Pol). Influenza A virus belongs to (UBF) at the rDNA promoter (Friedrich et al., 2005; Moss and the Orthomyxoviridae family, and its genome comprises eight Stefanovsky, 2002; Russell and Zomerdijk, 2006). Pol I, UBF and single-stranded RNAs of negative polarity (Naito et al., 2007). The viral RNA (vRNA) is associated with the viral RdR Pol, 1Department of Infection Biology, Faculty of Medicine and Graduate School of comprising PB1, PB2 and PA subunits, and nucleoprotein (NP), Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, forming viral ribonucleoprotein (vRNP) complexes (Nagata et al., Tsukuba, Ibaraki 305-8575, Japan. 2Kitasato Institute for Life Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan. 3Institute of Cancer 2008; Portela and Digard, 2002). The transcription promoter and Genetics and Pharmacogenomics, Division of Biosciences, School of Health the replication signal of the viral genome exist at the 39 and 59 Sciences and Social Care, Brunel University, Uxbridge, Middlesex UB8 3PH, UK. untranslated terminal regions (UTRs) of each segment. *Author for correspondence ([email protected]) Transcription of the influenza virus genome is initiated by the cap snatching mechanism (Li et al., 2001). The viral RdR Pol Received 21 November 2013; Accepted 25 May 2014 polyadenylates the nascent RNA chain, possibly by a slippage Journal of Cell Science 3309 RESEARCH ARTICLE Journal of Cell Science (2014) 127, 3309–3319 doi:10.1242/jcs.146787 mechanism at the adenylation signal which consists of five to the human rDNA promoter in a reporter plasmid but also seven uracil residues located near the 59 terminal of vRNA (Poon reactivated human rDNA in mouse cells containing the human et al., 1999). Thus, the synthesized RNA has the authentic chromosome 21 carrying an inactive human rDNA cluster. These eukaryotic mRNA structure. An influenza-virus-like particle results indicate that four TAFIs in human SL1 are necessary generation system was established based on the transfection of and sufficient to reconstitute a transcriptionally active SL1 and plasmid DNAs containing the viral genes under the control of the overcome the barrier of species specificity during rDNA Pol I promoter and terminator (Neumann et al., 1999; Zobel et al., transcription in mouse cells. 1993). In this system, an influenza virus genome RNA of an exact size and orientation is synthesized by cellular Pol I. When the RESULTS viral coding region is replaced with a reporter gene (see Fig. 1A), A novel reporter assay system for transcription by Pol I the reporter gene is expressed through the viral system described We developed a novel and sensitive reporter assay system to above. We examined the mechanism of rDNA transcription. In monitor transcription by Pol I in order to precisely analyze the particular, we evaluated its species-specific property using this species barrier for rDNA transcription (Fig. 1A) by modifying the novel and highly sensitive assay system, as we considered the original method (Zobel et al., 1993) for the influenza-virus-like possibility that the species-specificity contradiction might be particle generation system. In this system, engineered vRNA caused by reconstituted Pol I with an activity less than the containing a firefly luciferase (Luc) gene or an EGFP gene detectable level of conventional assay systems. sandwiched between 59- and 39-terminal cis-acting regulatory In the present study, we established a viral RdR Pol-based regions is synthesized by Pol I under the control of the promoter reporter system to monitor Pol I transcription. Using this and terminator in transfected cells. PA, PB1, PB2 and NP are monitoring system, we succeeded in reconstituting Pol I supplied from expression vectors under the control of the Pol transcription from human rDNA in mouse cells by exogenously II promoter (Neumann et al., 1999). mRNA encoding Luc is expressing human TAFIA, B, C and D in the SL1 complex, but synthesized by the influenza viral RdR Pol using RNA not with human TAFIA, TAFIB and TAFIC. Exogenous transcribed by Pol I as a template and the cellular cap structure expression of four TAFIs not only induced transcription from as a primer (Li et al., 2001; Poon et al., 1999). The synthesized Fig. 1. An RdR Pol-based reporter assay system for the transcription by Pol I. (A) A schematic representation of the influenza virus RNA-dependent RNA polymerase (RdR Pol)-mediated Pol I reporter assay system. The influenza virus model RNA genomes are expressed from phPolI-vNS-Luc or phPolI-vNA- EGFP (denoted ‘Luc. or EGFP’) by Pol I. The influenza virus RdR Pol amplifies the synthesized RNA and transcribes mRNA from the model viral RNA of negative polarity. (B) Dependency of the Pol I reporter assay system on viral polymerases and NP. The Luc activity was normalized to the Renilla luciferase activity expressed under the control of the SV40 promoter, a typical Pol II promoter. AU, arbitrary units. Results are mean6s.d. obtained from three independent experiments. (C) Evaluation of Pol I reporter systems. 3 Pol.+NP indicates transfection of plasmids containing RdR Pol components and NP. IRES and PolyA indicate an internal ribosome entry site and a poly(A) signal, respectively. (D) Expression of EGFP in the RdR Pol-based system. HeLa cells were co-transfected with plasmids expressing PA, PB1, PB2 and NP, and phPolI-vNA-EGFP (left panels).
Recommended publications
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Rabbit Anti-TAF1C/FITC Conjugated Antibody
    SunLong Biotech Co.,LTD Tel: 0086-571- 56623320 Fax:0086-571- 56623318 E-mail:[email protected] www.sunlongbiotech.com Rabbit Anti-TAF1C/FITC Conjugated antibody SL24053R-FITC Product Name: Anti-TAF1C/FITC Chinese Name: FITC标记的TATA盒Binding protein相关因子TAF1C抗体 RNA polymerase I-specific TBP-associated factor 110 kDa; SL1; Taf1c; TAF1C_MOUSE; TAFI110; TAFI95; TATA box binding protein associated factor 1C; TATA box-binding protein-associated factor 1C; TATA box-binding protein-associated Alias: factor RNA polymerase I subunit C; TBP associated factor 1C; TBP associated factor RNA polymerase I 95 kDa; TBP associated factor, RNA polymerase I, 110-KD; TBP- associated factor 1C; Transcription initiation factor SL1/TIF-IB subunit C. Organism Species: Rabbit Clonality: Polyclonal React Species: ICC=1:50-200IF=1:50-200 Applications: not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. Molecular weight: 95kDa Form: Lyophilized or Liquid Concentration: 2mg/1ml immunogen: KLHwww.sunlongbiotech.com conjugated synthetic peptide derived from mouse TAF1C Lsotype: IgG Purification: affinity purified by Protein A Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year Storage: when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. background: Initiation of transcription by RNA polymerase I requires the formation of a complex Product Detail: composed of the TATA-binding protein (TBP) and three TBP-associated factors (TAFs) specific for RNA polymerase I.
    [Show full text]
  • Bidirectional Cooperation Between Ubtf1 and SL1 Determines RNA Polymerase I Promoter
    bioRxiv preprint doi: https://doi.org/10.1101/2021.06.07.447350; this version posted June 7, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Bidirectional cooperation between Ubtf1 and SL1 determines RNA Polymerase I promoter 2 recognition in cell and is negatively affected in the UBTF-E210K neuroregression syndrome. 3 4 Michel G. Tremblay1, Dany S. Sibai1,2, Melissa Valère1,2, Jean-Clément Mars1,2,+, Frédéric Lessard1, 5 Roderick T. Hori3, Mohammad M. Khan4, Victor Y. Stefanovsky1, Mark S. Ledoux5 and Tom Moss1,2*. 6 7 1Laboratory of Growth and Development, St-Patrick Research Group in Basic Oncology, Cancer 8 Division of the Quebec University Hospital Research Centre, Québec, Canada. 2Department of 9 Molecular Biology, Medical Biochemistry and Pathology, Faculty of Medicine, Laval University, 10 Québec, Canada. 3Departments of Microbiology, Immunology and Biochemistry and 4Departments of 11 Neurology and Anatomy & Neurobiology, University of Tennessee Health Science Center, Memphis, 12 TN, USA. 5Department of Psychology, University of Memphis, Memphis TN and Veracity 13 Neuroscience LLC, Memphis, TN 14 15 +Present address, IRIC, Université de Montréal, Montréal, Québec, Canada 16 17 Correspondence should be addressed to; 18 Tom Moss, PhD, 19 Edifice St Patrick, 9 rue McMahon, Québec, QC, G1R 3S3, Canada. 20 E-mail. [email protected] 21 Tel. 1 418 691 5281 22 FAX 1 418 691 5439 23 24 Short title: Ubtf1-SL1 cooperation and the Ubtf-E210K syndrome.
    [Show full text]
  • Cross-Cohort Analysis Identifies a TEAD4– MYCN Positive Feedback Loop As the Core Regulatory Element of High-Risk Neuroblastoma
    Cross-Cohort Analysis Identifies a TEAD4– MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Rajbhandari, Presha et al. “Cross-Cohort Analysis Identifies a TEAD4–MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma.” Cancer Discovery 8, 5 (March 2018): 582–599 © 2018 AACR As Published http://dx.doi.org/10.1158/2159-8290.CD-16-0861 Publisher American Association for Cancer Research Version Author's final manuscript Citable link http://hdl.handle.net/1721.1/117503 Terms of Use Creative Commons Attribution-Noncommercial-Share Alike Detailed Terms http://creativecommons.org/licenses/by-nc-sa/4.0/ HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Cancer Manuscript Author Discov. Author manuscript; Manuscript Author available in PMC 2018 August 01. Published in final edited form as: Cancer Discov. 2018 May ; 8(5): 582–599. doi:10.1158/2159-8290.CD-16-0861. Cross-cohort analysis identifies a TEAD4 ↔ MYCN positive- feedback loop as the core regulatory element of high-risk neuroblastoma Presha Rajbhandari1,2,$, Gonzalo Lopez1,3,$, Claudia Capdevila1, Beatrice Salvatori1, Jiyang Yu1,#, Ruth Rodriguez-Barrueco4,5, Daniel Martinez3, Mark Yarmarkovich3, Nina Weichert-Leahey6, Brian J. Abraham7, Mariano J Alvarez1, Archana Iyer1, Jo Lynne Harenza3, Derek Oldridge3, Katleen De Preter8, Jan Koster9, Shahab Asgharzadeh10,11, Robert
    [Show full text]
  • Whole Exome Sequencing in Families at High Risk for Hodgkin Lymphoma: Identification of a Predisposing Mutation in the KDR Gene
    Hodgkin Lymphoma SUPPLEMENTARY APPENDIX Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene Melissa Rotunno, 1 Mary L. McMaster, 1 Joseph Boland, 2 Sara Bass, 2 Xijun Zhang, 2 Laurie Burdett, 2 Belynda Hicks, 2 Sarangan Ravichandran, 3 Brian T. Luke, 3 Meredith Yeager, 2 Laura Fontaine, 4 Paula L. Hyland, 1 Alisa M. Goldstein, 1 NCI DCEG Cancer Sequencing Working Group, NCI DCEG Cancer Genomics Research Laboratory, Stephen J. Chanock, 5 Neil E. Caporaso, 1 Margaret A. Tucker, 6 and Lynn R. Goldin 1 1Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; 2Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; 3Ad - vanced Biomedical Computing Center, Leidos Biomedical Research Inc.; Frederick National Laboratory for Cancer Research, Frederick, MD; 4Westat, Inc., Rockville MD; 5Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; and 6Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA ©2016 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol.2015.135475 Received: August 19, 2015. Accepted: January 7, 2016. Pre-published: June 13, 2016. Correspondence: [email protected] Supplemental Author Information: NCI DCEG Cancer Sequencing Working Group: Mark H. Greene, Allan Hildesheim, Nan Hu, Maria Theresa Landi, Jennifer Loud, Phuong Mai, Lisa Mirabello, Lindsay Morton, Dilys Parry, Anand Pathak, Douglas R. Stewart, Philip R. Taylor, Geoffrey S. Tobias, Xiaohong R. Yang, Guoqin Yu NCI DCEG Cancer Genomics Research Laboratory: Salma Chowdhury, Michael Cullen, Casey Dagnall, Herbert Higson, Amy A.
    [Show full text]
  • Table of Contents Table of Contents
    Table of contents Table of contents................................................................................................................. 1 Summary ............................................................................................................................. 3 Abbreviations ...................................................................................................................... 4 Gene Symbols I - Incidentals .............................................................................................. 5 Gene symbols II - Target Gene Names ............................................................................... 6 1. Introduction........................................................................................................... 12 1.1. The Pathos of the Crab ..................................................................................... 12 1.2. Cancer in the Molecular Age - a genetic and epigenetic disease..................... 13 1.3. Tumoral evolution............................................................................................. 14 1.4. DNA repair systems .......................................................................................... 17 1.4.1. DNA Mismatch Repair.............................................................................. 18 1.4.2. Double-strand Break Repair..................................................................... 19 1.4.3. Direct Repair...........................................................................................
    [Show full text]
  • Reorganization of the Host Epigenome by a Viral Oncogene
    Downloaded from genome.cshlp.org on September 29, 2021 - Published by Cold Spring Harbor Laboratory Press Research Reorganization of the host epigenome by a viral oncogene Roberto Ferrari,1,2 Trent Su,1,3 Bing Li,1 Giancarlo Bonora,1,4 Amit Oberai,1 Yvonne Chan,1 Rajkumar Sasidharan,5 Arnold J. Berk,6,7 Matteo Pellegrini,2,5 and Siavash K. Kurdistani1,2,7,8,9 1Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, California 90095, USA; 2Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, California 90095, USA; 3Division of Oral Biology and Medicine, School of Dentistry, David Geffen School of Medicine, University of California, Los Angeles, California 90095, USA; 4UCLA Bioinformatics Interdepartmental Degree Program, David Geffen School of Medicine, University of California, Los Angeles, California 90095, USA; 5Department of Molecular, Cellular, and Developmental Biology, University of California, Los Angeles, California 90095, USA; 6Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, California 90095, USA; 7Molecular Biology Institute, University of California, Los Angeles, California 90095, USA; 8Department of Pathology and Laboratory of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California 90095, USA Adenovirus small e1a oncoprotein causes ~70% reduction in cellular levels of histone H3 lysine 18 acetylation (H3K18ac). It is unclear, however, where this dramatic reduction occurs genome-wide. ChIP-sequencing revealed that by 24 h after expression, e1a erases 95% of H3K18ac peaks in normal, contact-inhibited fibroblasts and replaces them with one-third as many at new genomic locations.
    [Show full text]
  • CASC3 Promotes Transcriptome-Wide Activation of Nonsense
    bioRxiv preprint doi: https://doi.org/10.1101/811018; this version posted October 21, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 2 CASC3 promotes transcriptome-wide activation of nonsense- 3 mediated decay by the exon junction complex 4 5 Jennifer V. Gerbracht1, Volker Boehm1, Thiago Britto-Borges2,3, Sebastian Kallabis4, Janica L. 6 Wiederstein4, Simona Ciriello1,5, Dominik U. Aschemeier1, Marcus Krüger4, Christian K. 7 Frese4,6, Janine Altmüller7,8, Christoph Dieterich2,3, Niels H. Gehring1 8 1 Institute for Genetics, University of Cologne, 50674 Cologne, Germany 9 2 Section of Bioinformatics and Systems Cardiology, Department of Internal Medicine III and Klaus 10 Tschira Institute for Integrative Computational Cardiology, University of Heidelberg, 69120 Heidelberg, 11 Germany 12 3 DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120 13 Heidelberg, Germany 14 4 CECAD Research Center, University of Cologne, Joseph-Stelzmann-Str. 26, 50931 Cologne, Germany 15 5 present address: AO Research Institute Davos, Clavadelerstrasse 8, CH-7270 Davos Platz, Switzerland 16 6 present address: Max Planck Unit for the Science of Pathogens, 10117 Berlin, Germany 17 7 Cologne Center for Genomics (CCG), University of Cologne, 50931 Cologne, Germany 18 8 Center for Molecular Medicine Cologne, University of Cologne, 50937 Cologne, Germany 19 20 21 Contact 22 Niels H. Gehring, University of Cologne, Institute for Genetics, Zuelpicher Str. 47a, 50674 Cologne, 23 Germany; email: [email protected] 24 25 26 27 Running Title (40 Characters) 28 CASC3 promotes EJC-dependent NMD 29 Keywords (5, alphabetical order, separated by slash) 30 CRISPR-Cas9/gene expression/mRNA quality control/NMD/RNA degradation 31 1 bioRxiv preprint doi: https://doi.org/10.1101/811018; this version posted October 21, 2019.
    [Show full text]
  • Full-Text.Pdf
    Systematic Evaluation of Genes and Genetic Variants Associated with Type 1 Diabetes Susceptibility This information is current as Ramesh Ram, Munish Mehta, Quang T. Nguyen, Irma of September 23, 2021. Larma, Bernhard O. Boehm, Flemming Pociot, Patrick Concannon and Grant Morahan J Immunol 2016; 196:3043-3053; Prepublished online 24 February 2016; doi: 10.4049/jimmunol.1502056 Downloaded from http://www.jimmunol.org/content/196/7/3043 Supplementary http://www.jimmunol.org/content/suppl/2016/02/19/jimmunol.150205 Material 6.DCSupplemental http://www.jimmunol.org/ References This article cites 44 articles, 5 of which you can access for free at: http://www.jimmunol.org/content/196/7/3043.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 23, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Systematic Evaluation of Genes and Genetic Variants Associated with Type 1 Diabetes Susceptibility Ramesh Ram,*,† Munish Mehta,*,† Quang T.
    [Show full text]
  • Granulocyte Colony-Stimulating Factor-Induced TAF9 Modulates P53-TRIAP1-CASP3 Axis to Prevent Retinal Ganglion Cell Death After Optic Nerve Ischemia
    Granulocyte Colony-Stimulating Factor-Induced TAF9 Modulates P53-TRIAP1-CASP3 Axis to Prevent Retinal Ganglion Cell Death after Optic Nerve Ischemia Yao-Tseng Wen Buddhist Tzu Chi General Hospital Hualien: Hualien Tzu Chi Hospital Keh-Liang Lin Chung Shan Medical University Hospital Chin-Te Huang Tzu Chi University Rong Kung Tsai ( [email protected] ) Hualien Tzu Chi Hospital https://orcid.org/0000-0001-8760-5739 Research article Keywords: Granulocyte colony-stimulating factor, Rat anterior ischemic optic neuropathy model, Retinal ganglion cell, TBP associated factor 9, TP53, TRIAP1 Posted Date: January 6th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-138908/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/25 Abstract Background Optic nerve head (ONH) infarct can result in progressive retinal ganglion cell (RGC) death. Some evidences indicated that the granulocyte colony-stimulating factor (GCSF) provides positive effects against ischemic damage on RGCs. However, protective mechanisms of the GCSF after ONH infarct are complex and remain unclear. Methods To investigate the complex mechanisms, the transcriptome proles of the GCSF-treated retinas were examined using microarray technology. The retinal mRNA samples on days 3 and 7 post rat anterior ischemic optic neuropathy model (rAION) were analyzed by microarray and bioinformatics analyses. To evaluate the TAF9 function in RGC apoptosis, GCSF plus TAF9 siRNA-treated rats were evaluated using retrograde labeling with FluoroGold assay, TUNEL assay, and Western blotting in a rAION. Results GCSF treatment inuenced 3101 genes and 3332 genes on days 3 and 7 post rAION, respectively.
    [Show full text]
  • Exposure to Childhood Abuse Is Associated with Human Sperm DNA Methylation Andrea L
    Roberts et al. Translational Psychiatry (2018) 8:194 DOI 10.1038/s41398-018-0252-1 Translational Psychiatry ARTICLE Open Access Exposure to childhood abuse is associated with human sperm DNA methylation Andrea L. Roberts 1, Nicole Gladish2,EvanGatev2,3, Meaghan J. Jones 2,YingChen4, Julia L. MacIsaac2, Shelley S. Tworoger4,5,S.BrynAustin6, Cigdem Tanrikut7, Jorge E. Chavarro4,5,8,AndreaA.Baccarelli9 and Michael S. Kobor 2,10 Abstract Offspring of persons exposed to childhood abuse are at higher risk of neurodevelopmental and physical health disparities across the life course. Animal experiments have indicated that paternal environmental stressors can affect sperm DNA methylation and gene expression in an offspring. Childhood abuse has been associated with epigenetic marks in human blood, saliva, and brain tissue, with statistically significant methylation differences ranging widely. However, no studies have examined the association of childhood abuse with DNA methylation in gametes. We examined the association of childhood abuse with DNA methylation in human sperm. Combined physical, emotional, and sexual abuse in childhood was characterized as none, medium, or high. DNA methylation was assayed in 46 sperm samples from 34 men in a longitudinal non-clinical cohort using HumanMethylation450 BeadChips. We performed principal component analysis and examined the correlation of principal components with abuse exposure. Childhood abuse was associated with a component that captured 6.2% of total variance in DNA methylation (p < 0.05). Next, we investigated the regions differentially methylated by abuse exposure. We identified 12 DNA regions differentially methylated by childhood abuse, containing 64 probes and including sites on genes associated with 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; neuronal function (MAPT, CLU), fat cell regulation (PRDM16), and immune function (SDK1).
    [Show full text]
  • Platform Abstracts
    American Society of Human Genetics 65th Annual Meeting October 6–10, 2015 Baltimore, MD PLATFORM ABSTRACTS Wednesday, October 7, 9:50-10:30am Abstract #’s Friday, October 9, 2:15-4:15 pm: Concurrent Platform Session D: 4. Featured Plenary Abstract Session I Hall F #1-#2 46. Hen’s Teeth? Rare Variants and Common Disease Ballroom I #195-#202 Wednesday, October 7, 2:30-4:30pm Concurrent Platform Session A: 47. The Zen of Gene and Variant 15. Update on Breast and Prostate Assessment Ballroom III #203-#210 Cancer Genetics Ballroom I #3-#10 48. New Genes and Mechanisms in 16. Switching on to Regulatory Variation Ballroom III #11-#18 Developmental Disorders and 17. Shedding Light into the Dark: From Intellectual Disabilities Room 307 #211-#218 Lung Disease to Autoimmune Disease Room 307 #19-#26 49. Statistical Genetics: Networks, 18. Addressing the Difficult Regions of Pathways, and Expression Room 309 #219-#226 the Genome Room 309 #27-#34 50. Going Platinum: Building a Better 19. Statistical Genetics: Complex Genome Room 316 #227-#234 Phenotypes, Complex Solutions Room 316 #35-#42 51. Cancer Genetic Mechanisms Room 318/321 #235-#242 20. Think Globally, Act Locally: Copy 52. Target Practice: Therapy for Genetic Hilton Hotel Number Variation Room 318/321 #43-#50 Diseases Ballroom 1 #243-#250 21. Recent Advances in the Genetic Basis 53. The Real World: Translating Hilton Hotel of Neuromuscular and Other Hilton Hotel Sequencing into the Clinic Ballroom 4 #251-#258 Neurodegenerative Phenotypes Ballroom 1 #51-#58 22. Neuropsychiatric Diseases of Hilton Hotel Friday, October 9, 4:30-6:30pm Concurrent Platform Session E: Childhood Ballroom 4 #59-#66 54.
    [Show full text]